These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35544526)

  • 1. Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.
    Cannavo C; Cleverley K; Maduro C; Mumford P; Moulding D; Fisher EMC; Wiseman FK
    PLoS One; 2022; 17(5):e0262558. PubMed ID: 35544526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.
    Jiang Y; Mullaney KA; Peterhoff CM; Che S; Schmidt SD; Boyer-Boiteau A; Ginsberg SD; Cataldo AM; Mathews PM; Nixon RA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1630-5. PubMed ID: 20080541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.
    Wiseman FK; Pulford LJ; Barkus C; Liao F; Portelius E; Webb R; Chávez-Gutiérrez L; Cleverley K; Noy S; Sheppard O; Collins T; Powell C; Sarell CJ; Rickman M; Choong X; Tosh JL; Siganporia C; Whittaker HT; Stewart F; Szaruga M; ; Murphy MP; Blennow K; de Strooper B; Zetterberg H; Bannerman D; Holtzman DM; Tybulewicz VLJ; Fisher EMC;
    Brain; 2018 Aug; 141(8):2457-2474. PubMed ID: 29945247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models.
    Tosh JL; Rhymes ER; Mumford P; Whittaker HT; Pulford LJ; Noy SJ; Cleverley K; ; Walker MC; Tybulewicz VLJ; Wykes RC; Fisher EMC; Wiseman FK
    Sci Rep; 2021 Mar; 11(1):5736. PubMed ID: 33707583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21.
    Mumford P; Tosh J; Anderle S; Gkanatsiou Wikberg E; Lau G; Noy S; Cleverley K; Saito T; Saido TC; Yu E; Brinkmalm G; Portelius E; Blennow K; Zetterberg H; Tybulewicz V; Fisher EMC; Wiseman FK
    J Neurosci; 2022 Aug; 42(33):6453-6468. PubMed ID: 35835549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production.
    Chang JL; Hinrich AJ; Roman B; Norrbom M; Rigo F; Marr RA; Norstrom EM; Hastings ML
    Mol Ther; 2018 Jun; 26(6):1539-1551. PubMed ID: 29628304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
    Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
    Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).
    Jiang Y; Sato Y; Im E; Berg M; Bordi M; Darji S; Kumar A; Mohan PS; Bandyopadhyay U; Diaz A; Cuervo AM; Nixon RA
    J Neurosci; 2019 Jul; 39(27):5255-5268. PubMed ID: 31043483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.
    Furusawa K; Takasugi T; Chiu YW; Hori Y; Tomita T; Fukuda M; Hisanaga SI
    J Biol Chem; 2019 Jul; 294(28):10886-10899. PubMed ID: 31138646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease.
    Prasad H; Rao R
    J Biol Chem; 2015 Feb; 290(9):5311-27. PubMed ID: 25561733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production.
    Grbovic OM; Mathews PM; Jiang Y; Schmidt SD; Dinakar R; Summers-Terio NB; Ceresa BP; Nixon RA; Cataldo AM
    J Biol Chem; 2003 Aug; 278(33):31261-8. PubMed ID: 12761223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease.
    Tcw J; Goate AM
    Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nascent Aβ42 Fibrillization in Synaptic Endosomes Precedes Plaque Formation in a Mouse Model of Alzheimer's-like β-Amyloidosis.
    Eckman EA; Clausen DM; Solé-Domėnech S; Lee CW; Sinobas-Pereira C; Domalewski RJ; Nichols MR; Pacheco-Quinto J
    J Neurosci; 2023 Dec; 43(50):8812-8824. PubMed ID: 37884349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against the overexpression of APP in Down syndrome.
    Argellati F; Massone S; d'Abramo C; Marinari UM; Pronzato MA; Domenicotti C; Ricciarelli R
    IUBMB Life; 2006 Feb; 58(2):103-6. PubMed ID: 16608822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.
    Jiang Y; Rigoglioso A; Peterhoff CM; Pawlik M; Sato Y; Bleiwas C; Stavrides P; Smiley JF; Ginsberg SD; Mathews PM; Levy E; Nixon RA
    Neurobiol Aging; 2016 Mar; 39():90-8. PubMed ID: 26923405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AMY antigen co-occurs with abeta and follows its deposition in the amyloid plaques of Alzheimer's disease and down syndrome.
    Lemere CA; Grenfell TJ; Selkoe DJ
    Am J Pathol; 1999 Jul; 155(1):29-37. PubMed ID: 10393833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane.
    Wang M; Jing T; Wang X; Yao D
    Neurosci Lett; 2018 Oct; 685():63-67. PubMed ID: 30120949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.